In this study, BAG3 expression was evaluated in 104 HNSCC samples from various tumor sites, and samples with high BAG3 expression were found to have a significantly higher risk of recurrence compared to BAG3-negative samples. The gene discussed is BAG3; the disease is head and neck squamous cell carcinoma.